Immunovia announced that its U.S. subsidiary, Immunovia Inc., has appointed a new National Sales Director. Jon Hager starts in his position and has an extensive track record as a top-performing sales leader at companies like Ethos Labs, Myriad Genetics and Pfizer. He has earned multiple sales awards and promotions for his results and brings a wealth of experience growing new products, including at Myriad Genetics where he was a core member of the team that launched hereditary cancer testing to gynecologists.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.438 SEK | +1.99% | -3.49% | -18.85% |
21/05 | Immunovia Seeks SEK70 Million from Proposed Rights Offering | MT |
29/04 | Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024 |
1st Jan change | Capi. | |
---|---|---|
-18.85% | 6.02M | |
-25.18% | 17.05B | |
-40.23% | 2.84B | |
+15.23% | 1.85B | |
-5.65% | 1.56B | |
+33.13% | 1.36B | |
-18.62% | 924M | |
-25.88% | 856M | |
-26.78% | 604M | |
+24.29% | 573M |
- Stock Market
- Equities
- IMMNOV Stock
- News Immunovia AB
- Immunovia Inc. Appoints Jon Hager as New National Sales Director